Pfizer, Inc. (PFE)
A research-based, pharmaceutical Company which discovers, develops, manufactures and markets prescription medicines for humans and animals.
Recs
Strong Sector for 2010
Recs
Here is a company that has gamed the FDA process succesfully only to be found out later according to its history of fines. Their R&D has not delivered according to Fools, neither has Wyeth's, according to Fools. They are closing R&D facilities which makes sense if they haven't delivered a nice pipeline. They have cash and they will probably buy new R&D facilities and the companys that go with them. At least that's what I would do. Will Pfizer do it succesfully? From my vantage point as a mechanic I don't know, but I can guess. Outperform. No real life money though, this company should have been shut down, not just fined for its repetitive offenses.
Recs
Well-run and cash-rich.. Demographics favor this company.
Recs
Changes in reimbursement as health care costs are rationalized.
Recs
value, dividend
Recs
Cake Dex test run
Recs
After healthcare reforms the pimps will be gone and the benefit will go to the patients and indirectly to the pharmacuticals
Recs
Recs
it is viagra for the S&P500
Recs
good company, meds for boomers, always chance for block buster drug
Recs
I actually bought this stock under $16.50 months ago and have been waiting for this acquisition to take place. Right now everything is in place for this stock to break the $20 range by end of year. Plus they have a solid dividend that is not going anywhere anytime soon
Recs
Awesome company with 15 plus pending FDA approval for drugs.
Recs
Flu epidemic. Current proposal to FDA over HIV medicine.
Recs
This account tracks the performance of the investment firm Ruane, Cunniff, and Goldfarb - the investment manager of Sequoia Fund.
Recs
global name known for decades and their research will get this stock ahead of their competitors
Recs
The Wyeth acquisition will probably weigh down the stocks for a while, but gaining that pipeline of potential drugs and product should pay off in a couple of years. The management also seems to be devoted to streamlining research and development and to focusing on high-potential projects.
Recs
worked for the company for 28 years
Recs
astounding balance sheet
Recs
Drug companies manufacture money in the form of little pills. The population is getting older and needs more pills to keep going, ergo: more money for Pfizer.
Recs
Low P/E, solid company, getting very little value placed on the current pipeline. Looks reasonable timing on a technical basis too, having recently broken above the 200 day mva.

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 940 1 2 3 4 5 6 7 8 9 10 Next »